ARTICLE
- CNBC
(2020)
The ACTIV-3 trial is one of several ongoing trials that are part of an NIH program to accelerate the development of vaccine treatments.
Visibility: Public (all visitors)
Comments
Related Chunks
Related chunks with this resource
Antibody injections, treatment - a leading candidate for COVID19 Coronavirus cure
No comments yet. Be the first to comment!